PIK3CA and colonic neoplasm: It was found found cotreatment of drug-resistant colon cancer cells with the topoisomerase inhibitor doxorubicin and LY294002 resulted in massive apoptosis, suggesting that the PI3K pathway controls cell survival and drug resistance in these cells [441].